Skip to main content
Clinical Trials/NCT02621307
NCT02621307CompletedPhase 1

The Effect of Salba (Salvia Hispanica L) Versus Flax on Postprandial Blood Glucose Response and Subjective Appetite in Healthy Individuals

Unity Health Toronto1 site in 1 country15 target enrollmentStarted: July 1, 2010Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
15
Locations
1
Primary Endpoint
Change in Postprandial Blood Glucose

Study Overview

Brief Summary

The purpose of this study is to determine whether drinks containing Salvia hispanica L (Salba) or Flax lower postprandial blood glucose levels and improve appetite in healthy individuals.

Detailed Description

Dietary fibre has been implicated in improving many risk factors associated with Type 2 Diabetes and Cardiovascular Disease (CVD). However, on average, Norther Americans consume less than half of the recommended amount set by health agencies. It has been proposed that the health benefits of dietary fibre may be attritbuted to rheological characteristics such as viscosity. Salvia hispanica L (Salba) and Flax are nutritionally similar. The primary objective of this research trial is to study the effects of Salba and Flax on postprandial glycemia and appetite in healthy individuals.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Prevention
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •BMI less than 35 kg/m^2

Exclusion Criteria

  • •known history of liver or kidney disease, diabetes, hypertension, stroke, or myocardial infarctions, thyroid disease, gastrointestinal disease, or AIDS
  • •subjects using medications or Natural Health Products

Arms & Interventions

Salba

Experimental

50g glucose 25g ground Salba (Salba Corporation Ltd, Buenos Aires, Argentina) 200ml water

Intervention: Salba (Dietary Supplement)

Flax

Experimental

50g glucose 31g ground Flax (Bob's Red Mill Natural Raw Whole Flaxseed) 200ml water

Intervention: Flax (Dietary Supplement)

Control

Placebo Comparator

50g glucose 200ml water

Intervention: Control (Dietary Supplement)

Outcomes

Primary Outcomes

Change in Postprandial Blood Glucose

Time Frame: 2 Hours

At each visit, postprandial blood glucose will be measured via capillary blood samples, at 15, 30, 45, 60, 90, and 120 minutes after intake of test meals

Secondary Outcomes

  • Change in Subjective Satiety(2 Hours)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Vladimir Vuksan

Research Scientist & Professor

Unity Health Toronto

Study Sites (1)

Loading locations...

Similar Trials